Literature DB >> 26829425

Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.

Harald Hoffmann1,2, Thomas A Kohl3, Sabine Hofmann-Thiel1,2, Matthias Merker3,4, Patrick Beckert3,4, Katia Jaton5, Lubov Nedialkova2, Evgeni Sahalchyk2, Thomas Rothe6, Peter M Keller7, Stefan Niemann3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26829425     DOI： 10.1164/rccm.201502-0372LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  39 in total

Review 1.  The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance.

Authors:  Ahmed A Abulfathi; Peter R Donald; Kim Adams; Elin M Svensson; Andreas H Diacon; Helmuth Reuter
Journal:  Br J Clin Pharmacol       Date:  2020-06-21       Impact factor: 4.335

2.  Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.

Authors:  Suha Kadura; Nicholas King; Maria Nakhoul; Hongya Zhu; Grant Theron; Claudio U Köser; Maha Farhat
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

3.  Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis.

Authors:  Dalin Rifat; Si-Yang Li; Thomas Ioerger; Keshav Shah; Jean-Philippe Lanoix; Jin Lee; Ghader Bashiri; James Sacchettini; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.

Authors:  S Battaglia; A Spitaleri; A M Cabibbe; C J Meehan; C Utpatel; N Ismail; S Tahseen; A Skrahina; N Alikhanova; S M Mostofa Kamal; A Barbova; S Niemann; R Groenheit; A S Dean; M Zignol; L Rigouts; D M Cirillo
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

5.  Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.

Authors:  Masaji Okada; Yoko Kita; Satomi Hashimoto; Hitoshi Nakatani; Shiho Nishimastu; Yumiko Kioka; Yasuko Takami
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

6.  Adduct Formation of Delamanid with NAD in Mycobacteria.

Authors:  Mikayo Hayashi; Akihito Nishiyama; Ryuki Kitamoto; Yoshitaka Tateishi; Mayuko Osada-Oka; Yukiko Nishiuchi; Shaban A Kaboso; Xiuhao Chen; Mamoru Fujiwara; Yusuke Inoue; Yoshikazu Kawano; Masanori Kawasaki; Tohru Abe; Tsutomu Sato; Kentaro Kaneko; Kimiko Itoh; Sohkichi Matsumoto; Makoto Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 7.  Bedaquiline: Fallible Hope Against Drug Resistant Tuberculosis.

Authors:  Priya Singh; Rashmi Kumari; Rup Lal
Journal:  Indian J Microbiol       Date:  2017-10-24       Impact factor: 2.461

8.  Antitubercular Triazines: Optimization and Intrabacterial Metabolism.

Authors:  Xin Wang; Daigo Inoyama; Riccardo Russo; Shao-Gang Li; Ravindra Jadhav; Thomas P Stratton; Nisha Mittal; Joseph A Bilotta; Eric Singleton; Thomas Kim; Steve D Paget; Richard S Pottorf; Yong-Mo Ahn; Alejandro Davila-Pagan; Srinivasan Kandasamy; Courtney Grady; Seema Hussain; Patricia Soteropoulos; Matthew D Zimmerman; Hsin Pin Ho; Steven Park; Véronique Dartois; Sean Ekins; Nancy Connell; Pradeep Kumar; Joel S Freundlich
Journal:  Cell Chem Biol       Date:  2019-11-08       Impact factor: 8.116

9.  Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.

Authors:  Keira A Cohen; Katharine E Stott; Vanisha Munsamy; Abigail L Manson; Ashlee M Earl; Alexander S Pym
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

10.  Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing.

Authors:  Hans-Peter Grobbel; Matthias Merker; Niklas Köhler; Sönke Andres; Harald Hoffmann; Jan Heyckendorf; Maja Reimann; Ivan Barilar; Viola Dreyer; Doris Hillemann; Barbara Kalsdorf; Thomas A Kohl; Patricia Sanchez Carballo; Dagmar Schaub; Katharina Todt; Christian Utpatel; Florian P Maurer; Christoph Lange; Stefan Niemann
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.